🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
AUR
$AURA
🔒 US EquitiesAura Biosciences, Inc.
AVG HISTORICAL GAP
+0.54%
MAX GAP RECORD
+8.69%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $AURA
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$AURA
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Aug 11, 2026 Earnings Release 2026-08-11 (AFTER CLOSE) |
-3.36%
|
| Mar 30, 2026 Earnings Release 2026-03-30 (AFTER CLOSE) |
+3.23%
|
| Nov 13, 2025 Earnings Release 2025-11-13 (AFTER CLOSE) |
-2.35%
|
| Aug 13, 2025 Earnings Release 2025-08-13 (AFTER CLOSE) |
-1.52%
|
| May 15, 2025 Earnings Release 2025-05-15 (BEFORE OPEN) |
-7.55%
|
| Mar 24, 2025 Earnings Release 2025-03-24 (AFTER CLOSE) |
-0.57%
|
| Nov 12, 2024 Earnings Release 2024-11-12 (AFTER CLOSE) |
+3.66%
|
| Aug 08, 2024 Earnings Release 2024-08-08 (BEFORE OPEN) |
+4.27%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
3.1%
Bullish Gaps (6)
Bearish Gaps (5)
Neutral / Flat (2)
📖 Intelligence Summary
Aura Biosciences, Inc., a clinical-stage biotechnology company, develops precision therapies to treat solid tumors. The company's proprietary platform enables the targeting of a range of solid tumors using virus-like particles conjugated with drugs or loaded with nucleic acids to create virus-like drug conjugates. Its lead candidate is bel-sar, which is…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗